850429-60-6 Usage
General Description
Methyl 2-amino-5-bromothiazole-4-carboxylate is a chemical compound with the molecular formula C7H6BrN2O2S. It is a derivative of thiazole, a heterocyclic compound containing a five-membered ring with sulfur and nitrogen atoms. Methyl 2-amino-5-bromothiazole-4-carboxylate is commonly used in pharmaceutical and agrochemical research as a building block for the synthesis of various biologically active molecules. It possesses an amino group, a carboxylate group, and a bromine atom, all of which contribute to its diverse reactivity and potential applications in organic synthesis. Additionally, the methyl ester group makes it more soluble in organic solvents, allowing for ease of manipulation in laboratory settings.
Check Digit Verification of cas no
The CAS Registry Mumber 850429-60-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,4,2 and 9 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 850429-60:
(8*8)+(7*5)+(6*0)+(5*4)+(4*2)+(3*9)+(2*6)+(1*0)=166
166 % 10 = 6
So 850429-60-6 is a valid CAS Registry Number.
InChI:InChI=1/C5H5BrN2O2S/c1-10-4(9)2-3(6)11-5(7)8-2/h1H3,(H2,7,8)
850429-60-6Relevant articles and documents
2-(1H-INDOLE-3-CARBONYL)-THIAZOLE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS
-
Paragraph 00162; 00289, (2021/06/26)
2-(1H-lndole-3-carbonyl)-thiazole-4-carboxamide derivatives and the corresponding imidazole, oxazole and thiophene derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of angiogenesis implicated disorders, such as e.g. retinopathy, psoriasis, rheumatoid arthritis, obesity and cancer, or inflammatory disorders. The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 27 to 32 and 59 to 219; examples 1 to 8; compounds 1-1 to 1-97; tables 1-a, 2 and 3).